SSTR2 and cancer: Even if it is ultimately confirmed that SSTR2 is not among the specific markers of NEPC, the design concept of T-SMPDC and its modular synthesis presented in this work can be readily adapted to accommodate the rapid advances in the field of cancer innervation.